TARRIFF SCOTT (CEO) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/1/2024ACC: 0000950170-24-023945
DirectorOfficer· CEO
Since Jun 2018
-2.12K
Net shares
Net seller
$13.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.12K
Price / share
$6.27
Trade value
$13.29K
% of position
0.5%
2/28/2024
462.74K→460.62K
Total
Net shares
−2.12K
Net value
-$13.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2024 | F · Tax Withholding | −2.12K | $6.27 | $13.29K | 0.5% | 462.74K | 460.62K |
| Total | −2.12K | -$13.29K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned992.62K
Total
992.62K indirect992.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 992.62K | Indirect |
| Total | 992.62K | 992.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported